Free Research Preview. DrugChatter may produce inaccurate information.
![]() |
@MarcJacksonLA $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/SWr1CZsJIy April 17th 2023, 3:04pm |
![]() |
@otcdynamics $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/3KLrokItds April 17th 2023, 12:04pm |
![]() |
@otcdynamics $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/v7w6XQno3t April 17th 2023, 12:04pm |
![]() |
@James__BondOO7 RT @stock_titan: $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd European… April 17th 2023, 11:04am |
![]() |
@FlashAlert_me $ENTA [15s. delayed]: Issued Press Release on April 17, 07:00:00: Enanta Pharmaceuticals Presents Data for its COVI… https://t.co/80CxEUW7s4 April 17th 2023, 11:04am |
![]() |
@StockNewsBot2 $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/FgbjTEtIks April 17th 2023, 11:04am |
![]() |
@stock_titan $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/WIYKlDZPcl April 17th 2023, 11:04am |
![]() |
@WebChronicleTo1 $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/DbQ8nWYgbD April 17th 2023, 11:04am |
![]() |
@Tickeron This is why Hedge Funds use A.I. $ENTA RSI Indicator left the oversold zone. #EnantaPharmaceuticals… https://t.co/WD676YltRN April 13th 2023, 11:04pm |
![]() |
@LeviTrade2 $ENTA Buy rating based off 6 trades on the 15-min chart. #trading #stocks #wallstreet #webull #tradingview #tos ? C… https://t.co/txhpDrOJwA April 12th 2023, 11:04am |
![]() |
@TortozaPalma $ENTA Awaiting Buy Signal based off 6 signals on the 15-min chart. Free trial at https://t.co/OB4KuLJjyA https://t.co/3atUCYlztS April 12th 2023, 2:04am |
![]() |
@Tickeron How does this affect your portfolio? $ENTA RSI Indicator left the oversold zone. #EnantaPharmaceuticals… https://t.co/tECftg4R5r April 8th 2023, 6:04am |
![]() |
@StckPro $ENTA NEW ARTICLE : RBC Capital Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA) https://t.co/ghn5DA2Q5t April 8th 2023, 1:04am |
![]() |
@bkfViking123 RT @MarcJacksonLA: $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Developme… April 6th 2023, 3:04pm |
![]() |
@MarcJacksonLA $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/PLM0hxhYgW April 6th 2023, 3:04pm |
![]() |
@OzmosiHealth $ENTA receives FDA Fast Track Designation for EDP-323, an oral L-Protein inhibitor in development for the treatment… https://t.co/wpLdH2BLkJ April 6th 2023, 1:04pm |
![]() |
@Briefingcom $ENTA: Enanta Pharmaceuticals announces that the U.S. Food and Drug Administration has granted Fast Track... https://t.co/QwCPfvrVk2 April 6th 2023, 1:04pm |
![]() |
@realmaciej RT @BioStocks: $ENTA Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development for the Treatment of Res… April 6th 2023, 12:04pm |
![]() |
@otcdynamics $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/KiqFrdKSmp April 6th 2023, 12:04pm |
![]() |
@thudderwicks $ENTA said that the FDA has granted Fast Track designation for EDP-323, Enanta’s L-protein inhibitor in development… https://t.co/unKOzCgxpH April 6th 2023, 11:04am |
![]() |
@StckPro $ENTA NEW ARTICLE : Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inh… https://t.co/mJN6hHc4xd April 6th 2023, 11:04am |
![]() |
@Tradesense_me $ENTA ? ? Press Release Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protei… https://t.co/WiVxdsZTSj April 6th 2023, 11:04am |
![]() |
@TheTradeXchange $ENTA: Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Dev… https://t.co/2Abh9qn290 April 6th 2023, 11:04am |
![]() |
@James__BondOO7 RT @stock_titan: $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development… April 6th 2023, 11:04am |
![]() |
@FlashAlert_me $ENTA [15s. delayed]: Issued Press Release on April 06, 07:00:00: Enanta Pharmaceuticals Receives FDA Fast Track De… https://t.co/G20LDC1cj4 April 6th 2023, 11:04am |
![]() |
@BioStocks $ENTA Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development for the Treatme… https://t.co/i0Iyn8GAPY April 6th 2023, 11:04am |
![]() |
@StockNewsBot2 $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/btqfYCmPQ8 April 6th 2023, 11:04am |
![]() |
@WebChronicleTo1 $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/7TmHWeWQN7 April 6th 2023, 11:04am |
![]() |
@CHItraders $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/cy6tf7VQYl April 6th 2023, 11:04am |
![]() |
@stock_titan $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/8yQPFKfuux April 6th 2023, 11:04am |
![]() |
@bthefirsttoknow First out// $ENTA: Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhi… https://t.co/hJFtUIOQEV April 6th 2023, 11:04am |
![]() |
@otcdynamics $ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/Gz38WVsTUM April 5th 2023, 11:04am |
![]() |
@FlashAlert_me $ENTA [15s. delayed]: Issued Press Release on April 05, 07:00:00: Enanta Pharmaceuticals to Present Data at the 33r… https://t.co/dq53HVDFIt April 5th 2023, 11:04am |
![]() |
@Tradesense_me $ENTA ? ? Press Release Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiol… https://t.co/pHn0xlnpxi April 5th 2023, 11:04am |
![]() |
@StockNewsBot2 $ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/XIXx3hbefS April 5th 2023, 11:04am |
![]() |
@WebChronicleTo1 $ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/hxeMsqdMPP April 5th 2023, 11:04am |
![]() |
@stock_titan $ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/mRb8FQsuwE April 5th 2023, 11:04am |
![]() |
@ChartMill $ENTA is expected to show a strong revenue growth of 64.25% yearly. https://t.co/KkoF1p5wg1 https://t.co/mbyr11IHSk April 3rd 2023, 8:04pm |
![]() |
@StckPro $ENTA NEW ARTICLE : Enanta Pharmaceuticals (ENTA) Receives a Buy from JMP Securities https://t.co/KUXF3zaozP April 3rd 2023, 2:04pm |
![]() |
@Phoenix3million $enta entered 5k shares 2day. $rvnc entered 2.5K shares. very familiar w/ both for past 5 years. Current holdin… https://t.co/nxb18EFThO March 23rd 2023, 3:03pm |
![]() |
@StockAutomate $ENTA The chart is showing a bearish outlook for the stock. We alerted the SELL signal at $41.94 and we were able t… https://t.co/jftMrOzqxI March 22nd 2023, 5:03am |
![]() |
@fda_tracker $ENTA Phase 2 trial w/est Mar completion date NCT05616728: https://t.co/c9YEhMGw74 Trial Tracker: https://t.co/aR7q5osthn March 21st 2023, 1:03pm |
![]() |
@gtrades31 $ENTA Blocktrade Sale of $1.22M SHARES 29.35K ? Filled at Bid @ 41.73 #Blocktrades March 20th 2023, 9:03pm |
![]() |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 185 March 20th 2023, 9:03am |
![]() |
@mediasentiment $ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 184 March 20th 2023, 9:03am |
![]() |
@PaulTorresCohen Paul Torres-Cohen $ENTA March 20th 2023, 1:03am |
![]() |
@Tickeron $ENTA's 10-day Moving Average broke below its 50-day Moving Average on February 28, 2023. View odds for this and ot… https://t.co/rOPy1SzFX6 March 19th 2023, 4:03pm |
![]() |
@Tickeron How will this affect the market? $ENTA price may climb as it broke lower Bollinger Band. #EnantaPharmaceuticals… https://t.co/ixLFXG1Bhd March 18th 2023, 10:03pm |
![]() |
@FlashAlert_me $ENTA [15s. delayed] filed SEC form 4: Director Vance Terry: Converted securities 5,800 of Common Stock at price $… https://t.co/vFWYL5OYB0 March 17th 2023, 10:03pm |
![]() |
@day_trading_de ENTA (ENANTA PHARMACEUTICALS INC) ? #Insider #stock alert! ? #Sale on 2023-03-15 - $ENTA ??: MELLETT PAUL J (Treasu… https://t.co/c0gsH39H6h March 17th 2023, 10:03pm |
DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC
2004 - 2023. All rights reserved.